Annual Cash & Cash Equivalents
$62.99 M
+$7.49 M+13.49%
31 December 2023
Summary:
Gritstone bio annual cash & cash equivalents is currently $62.99 million, with the most recent change of +$7.49 million (+13.49%) on 31 December 2023. During the last 3 years, it has fallen by -$107.07 million (-62.96%). GRTS annual cash & cash equivalents is now -62.96% below its all-time high of $170.06 million, reached on 31 December 2020.GRTS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$50.90 M
+$8.51 M+20.06%
30 June 2024
Summary:
Gritstone bio quarterly cash and cash equivalents is currently $50.90 million, with the most recent change of +$8.51 million (+20.06%) on 30 June 2024. Over the past year, it has increased by +$21.36 million (+72.31%). GRTS quarterly cash and cash equivalents is now -70.07% below its all-time high of $170.06 million, reached on 31 December 2020.GRTS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GRTS Cash And Cash Equivalents Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +13.5% | +72.3% |
3 y3 years | -63.0% | -61.3% |
5 y5 years | +20.7% | -56.5% |
GRTS Cash And Cash Equivalents High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -63.0% | +13.5% | -61.3% | +72.3% |
5 y | 5 years | -63.0% | +20.7% | -70.1% | +72.3% |
alltime | all time | -63.0% | +407.5% | -70.1% | +72.3% |
Gritstone Bio Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
June 2024 | - | $50.90 M(+20.1%) |
Mar 2024 | - | $42.40 M(-32.7%) |
Dec 2023 | $62.99 M(+13.5%) | $62.99 M(+113.2%) |
Sept 2023 | - | $29.54 M(-28.7%) |
June 2023 | - | $41.41 M(-12.1%) |
Mar 2023 | - | $47.13 M(-15.1%) |
Dec 2022 | $55.50 M(-40.5%) | $55.50 M(-14.5%) |
Sept 2022 | - | $64.91 M(-1.2%) |
June 2022 | - | $65.69 M(-5.0%) |
Mar 2022 | - | $69.16 M(-25.9%) |
Dec 2021 | $93.29 M | $93.29 M(-29.0%) |
Sept 2021 | - | $131.42 M(+105.1%) |
June 2021 | - | $64.08 M(-40.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $108.50 M(-36.2%) |
Dec 2020 | $170.06 M(+196.2%) | $170.06 M(+195.0%) |
Sept 2020 | - | $57.65 M(-8.0%) |
June 2020 | - | $62.63 M(+14.2%) |
Mar 2020 | - | $54.86 M(-4.4%) |
Dec 2019 | $57.41 M(+10.0%) | $57.41 M(-50.9%) |
Sept 2019 | - | $116.94 M(+8.6%) |
June 2019 | - | $107.73 M(+211.6%) |
Mar 2019 | - | $34.57 M(-33.7%) |
Dec 2018 | $52.18 M(+33.8%) | $52.18 M(-20.9%) |
Sept 2018 | - | $65.94 M(+75.6%) |
June 2018 | - | $37.54 M(-3.8%) |
Dec 2017 | $39.01 M(+214.3%) | $39.01 M |
Dec 2016 | $12.41 M | - |
FAQ
- What is Gritstone bio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Gritstone bio?
- What is Gritstone bio annual cash & cash equivalents year-on-year change?
- What is Gritstone bio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Gritstone bio?
- What is Gritstone bio quarterly cash and cash equivalents year-on-year change?
What is Gritstone bio annual cash & cash equivalents?
The current annual cash & cash equivalents of GRTS is $62.99 M
What is the all time high annual cash & cash equivalents for Gritstone bio?
Gritstone bio all-time high annual cash & cash equivalents is $170.06 M
What is Gritstone bio annual cash & cash equivalents year-on-year change?
Over the past year, GRTS annual cash & cash equivalents has changed by +$7.49 M (+13.49%)
What is Gritstone bio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GRTS is $50.90 M
What is the all time high quarterly cash and cash equivalents for Gritstone bio?
Gritstone bio all-time high quarterly cash and cash equivalents is $170.06 M
What is Gritstone bio quarterly cash and cash equivalents year-on-year change?
Over the past year, GRTS quarterly cash and cash equivalents has changed by +$21.36 M (+72.31%)